Results 191 to 200 of about 61,734 (360)

Alcohol Septal Ablation to Prevent Left Ventricular Outflow Tract Obstruction During Transcatheter Mitral Valve Replacement: First-in-Man Study.

JACC: Cardiovascular Interventions, 2019
Dee Dee Wang, M. Guerrero, M. Eng, M. Eleid, C. Meduri, V. Rajagopal, Pradeep K Yadav, M. Fifer, I. Palacios, C. Rihal, T. Feldman, W. O’Neill   +11 more
semanticscholar   +1 more source

Impact of pregnancy termination law reforms in Ireland on pregnancy termination rates in the setting of fetal congenital heart disease: A trend analysis

International Journal of Gynecology &Obstetrics, Volume 169, Issue 2, Page 623-629, May 2025.
Abstract Objective Prior to 2019, termination of pregnancy (TOP) was unlawful in Ireland. We sought to examine the impact of legislative change on TOP for major congenital heart disease (CHD) and its effect on parental decision‐making regarding the options of complex surgery, TOP, or palliative perinatal care.
Fiona Cody, Nollaig Kelleher, Zara Molphy, Patrick Dicker, Fergal Malone, Sirisha Bellamkonda, Fiona Mc Elligott, Fionnuala M. Breathnach   +7 more
wiley   +1 more source

530 Mid-systolic septal deceleration - a new sign of left ventricular outflow tract obstruction obtained by colour-coded tissue Doppler echocardiography [PDF]

, 2003
Ole A. Breithardt, B. Stolle, Andreas Franke, Uwe Janssens, Peter Hanrath, H. Kuhn   +5 more
openalex   +1 more source

Drug–Drug Interaction Potential of Mavacamten with Midazolam: Combined Results from Clinical and Model‐Based Studies

The Journal of Clinical Pharmacology, Volume 65, Issue 5, Page 598-606, May 2025.
Abstract Mavacamten is a potential inducer of cytochrome P450 (CYP) 3A4 and could reduce the effectiveness of concomitant drugs that are metabolized by CYP3A4, such as midazolam. This study aimed to determine if repeat doses of mavacamten achieving clinically relevant exposures affected midazolam exposure.
Samira Merali, Caroline Sychterz, Vidya Perera, Lu Gaohua, Victoria Florea, Bindu Murthy   +5 more
wiley   +1 more source

Erratum to: Patients with mild hypertensive heart disease and left ventricular outflow tract obstruction: treatment with angiotensin II antagonists [PDF]

, 2004
Mikiko Nakagawa, Nario Sano, Seiki Nobe, Masashi Ichinose, Hidetoshi Yonemochi, Tetsunori Saikawa   +5 more
openalex   +1 more source

Dynamic left ventricular outflow tract obstruction

Kardiologia Polska, 2014
Robert Błaszczyk, Maciej Wójcik, Łukasz Konarski, Andrzej Tomaszewski, Andrzej Wysokiński   +4 more
openaire   +3 more sources

GABAB Receptor: Structure, Biological Functions, and Therapy for Diseases

MedComm, Volume 6, Issue 5, May 2025.
Within the GABAergic system, GABABRs are potential therapeutic targets for dealing multiple metabolic and binge eating disorders and food addiction. Allosteric modulators and small peptides targeting GABABR signaling pathways may be developed as attractive drug candidates that avoid the side effects of agents that directly bind these receptors ...
Weijie Xie, Yuan Li, Xinyue Wang, Elena Blokhina, Evgeny Krupitsky, Marina Vetrova, Ji Hu, Ti‐Fei Yuan, Jue Chen, Hua Wang, Xiangfang Chen   +10 more
wiley   +1 more source

Left ventricular outflow tract obstruction in patients with Ebstein anomaly. [PDF]

JTCVS Open, 2023
Ergi DG, Schaff HV, Connolly HM, Miranda WR, Majdalany DS, Dearani JM.   +5 more
europepmc   +1 more source

The Inflexible Mitral Annulus After Valve Prosthesis Inherent Risk of Dynamic Left Ventricular Outflow Tract Obstruction

, 1996
Takeshi Komoda, Roland Hetzer, J. Oellinger, Henryk Siniawski, J. Hofmeister, Michael Hübler, Roland Felix, Chikao Uyama, Hajime Maeta   +8 more
openalex   +1 more source

Surgical management of left ventricular outflow tract obstruction in a specialized hypertrophic obstructive cardiomyopathy center.

Journal of Thoracic and Cardiovascular Surgery, 2019
K. Hodges, C. G. Rivas, J. Aguilera, R. Borden, A. Alashi, E. Blackstone, M. Desai, N. Smedira   +7 more
semanticscholar   +1 more source